Gene editing saves Layla from leukaemia
22 January, 2016 by Lauren DavisIn an impressive demonstration of the power of gene editing, designer immune cells have been successfully used to treat an infant cancer patient.
Promega NanoLuc NanoBRET target engagement technology
20 January, 2016 | Supplied by: Promega Pty LtdPromega NanoLuc technology has been used to directly assess the dynamic process of target engagement in live cancer cells. The company's scientists have developed a method for use in drug discovery that measures target residence as a key aspect of target engagement in live cells.
Clinical trial disaster
18 January, 2016A Phase 1 clinical trial has gone seriously awry, with one volunteer now dead and others with serious, possibly irreversible, neurological damage.
Studying sepsis with protein patterns
18 January, 2016
A Swedish research team has developed a way to measure hundreds of proteins in a single blood sample, using these protein patterns to determine the severity of sepsis (blood poisoning) in individual patients.
Porvair Sciences Krystal UV assay microplates
15 January, 2016 | Supplied by: BMG LABTECH Pty LtdKrystal UV quartz-bottomed microplates from Porvair Sciences are designed for high-throughput applications which require excitation or detection wavelengths in the far UV region below 350 nm.
Dry and resoak: the new way to speed up bioassays
13 January, 2016US scientists have proposed a way to speed up the time it takes to conduct biological assays. Their solution, reminiscent of the science behind washing machines, could reduce wait times from hours to minutes.
SIFIN Diagnostics MICRONAUT anaerobe MIC plate and Wilkins Chalgren Broth
13 January, 2016 | Supplied by: Dutec Diagnostics Pty LtdThe MICRONAUT anaerobe MIC plate, from SIFIN Diagnostics, is now available together with the MICRONAUT Wilkins Chalgren Broth culture medium. Due to the choice of antibiotics on the MIC plate, it is appropriate for testing in the outpatient and hospital sectors.
An advance in Alzheimer's research
11 December, 2015 by Graeme O'NeillResearchers have identified a network of genes whose interactions influence the age at which carriers of the pathogenic E280A gene mutation will develop Alzheimer's disease.
Cancer detection with one drop of blood
27 November, 2015Researchers have developed an RNA test of blood platelets that can be used to detect cancer. By analysing a sample equivalent to one drop of blood, they were able to identify, classify and pinpoint the location of the cancer with impressive accuracy.
Shedding light on the dark proteome
25 November, 2015Scientists have long speculated about the nature of the dark proteome — the regions of proteins where molecular conformation is completely unknown.
Diatron Abacus Vet5 and Diatron Aquila haematology analysers
17 November, 2015 | Supplied by: The Diatron GroupThe Diatron Group has introduced the Abacus Vet5 five-part differential veterinary haematology analyser and the Diatron Aquila three-part differential human haematology analyser.
IDT xGen Exome Research Panel v1.0
11 November, 2015 | Supplied by: Integrated DNA TechnologiesIntegrated DNA Technologies (IDT) introduces its xGen Exome Research Panel v1.0 for insightful analysis of the human exome via next-generation sequencing. By using the research panel with xGen Lockdown Reagents and the optimised protocol, scientists can obtain reproducible exome data in a single day, minimising the need for added downstream analysis.
QIAGEN Clinical Insight bioinformatics platform expanded
06 November, 2015 | Supplied by: QIAGEN Pty Ltd
The QIAGEN Clinical Insight (QCI) clinical decision support solution streamlines the annotation, interpretation and reporting of next-generation sequencing results (NGS) for clinical laboratories. The bioinformatics platform has been expanded from interpreting NGS data on somatic mutations in solid tumour cancers to add leukaemia and lymphoma testing, as well as testing for hereditary cancer indications.
QIAGEN GeneReader NGS System
05 November, 2015 | Supplied by: QIAGEN Pty LtdQIAGEN has announced the start of commercialisation activities for its GeneReader NGS System, a Sample to Insight next-generation sequencing (NGS) solution that enables laboratories to deliver actionable results. The system offers an end-to-end NGS workflow from primary sample to a final report that provides a simple way for clinical testing to take advantage of NGS technology and improve outcomes.
REZOLVE SCIENTIFIC ReZolve-L1 cell-permeant stain for polar lipids
05 November, 2015 | Supplied by: REZOLVE SCIENTIFIC Pty LtdReZolve-L1 is a cell-permeant stain that is selective for polar lipids and can be used in a wide variety of live and fixed cells. The product provides high-quality and rapid lipid staining useful for fluorescent microscopy applications and automated imaging.
